NO20014362L - Erytromycinderivater - Google Patents

Erytromycinderivater

Info

Publication number
NO20014362L
NO20014362L NO20014362A NO20014362A NO20014362L NO 20014362 L NO20014362 L NO 20014362L NO 20014362 A NO20014362 A NO 20014362A NO 20014362 A NO20014362 A NO 20014362A NO 20014362 L NO20014362 L NO 20014362L
Authority
NO
Norway
Prior art keywords
erythromycin derivative
erythromycin
derivative
Prior art date
Application number
NO20014362A
Other languages
English (en)
Norwegian (no)
Other versions
NO20014362D0 (no
Inventor
Hideo Kato
Noriyuki Kado
Toshihiko Yoshida
Akemi Nishimoto
Ken Narita
Original Assignee
Hokuriku Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hokuriku Pharmaceutical filed Critical Hokuriku Pharmaceutical
Publication of NO20014362D0 publication Critical patent/NO20014362D0/no
Publication of NO20014362L publication Critical patent/NO20014362L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NO20014362A 1999-04-08 2001-09-07 Erytromycinderivater NO20014362L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10072699 1999-04-08
PCT/JP2000/002226 WO2000061593A1 (fr) 1999-04-08 2000-04-06 Derives d'erythromycine

Publications (2)

Publication Number Publication Date
NO20014362D0 NO20014362D0 (no) 2001-09-07
NO20014362L true NO20014362L (no) 2001-12-04

Family

ID=14281635

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014362A NO20014362L (no) 1999-04-08 2001-09-07 Erytromycinderivater

Country Status (19)

Country Link
EP (1) EP1167375A4 (tr)
KR (1) KR20020007333A (tr)
CN (1) CN1343216A (tr)
AR (1) AR023264A1 (tr)
AU (1) AU3671000A (tr)
BG (1) BG105919A (tr)
BR (1) BR0010518A (tr)
CA (1) CA2367319A1 (tr)
CZ (1) CZ20013497A3 (tr)
HK (1) HK1045697A1 (tr)
HU (1) HUP0201116A3 (tr)
IL (1) IL145256A0 (tr)
NO (1) NO20014362L (tr)
NZ (1) NZ513998A (tr)
PL (1) PL354409A1 (tr)
SK (1) SK13972001A3 (tr)
TR (1) TR200102572T2 (tr)
WO (1) WO2000061593A1 (tr)
ZA (1) ZA200107346B (tr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6946446B2 (en) 2000-02-24 2005-09-20 Abbott Laboratories Anti-infective agents useful against multidrug-resistant strains of bacteria
EP1259923B1 (en) * 2000-02-24 2005-12-14 Abbott Laboratories Anti-infective agents useful against mulitidrug-resistant strains of bacteria
JP2002173498A (ja) * 2000-09-27 2002-06-21 Hokuriku Seiyaku Co Ltd エリスロマイシン誘導体
UY27429A1 (es) * 2001-09-05 2003-10-31 Hokuriku Pharmaceutical Medicamento para el tratamiento terapéutico o preventivo de la tuberculosis que comprende un derivado de eritromicina
CA2801100A1 (en) 2003-03-10 2004-09-23 Optimer Pharmaceuticals, Inc. Macrolides and processes for their preparation
WO2004108744A2 (en) * 2003-05-19 2004-12-16 Prasad K Deshpande Azalides and azaketolides having antimicrobial activity
WO2006120541A1 (en) 2005-05-10 2006-11-16 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Ether linked macrolides useful for the treatment of microbial infections
CN105732745A (zh) 2007-10-25 2016-07-06 森普拉制药公司 大环内酯类抗菌剂的制备方法
CN107854477A (zh) 2008-10-24 2018-03-30 森普拉制药公司 使用含***的大环内酯治疗抗性疾病的方法
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
WO2011032052A1 (en) 2009-09-10 2011-03-17 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and mac diseases
PL2571506T3 (pl) * 2010-05-20 2017-10-31 Cempra Pharmaceuticals Inc Sposoby sporządzania makrolidów i ketolidów oraz ich produktów pośrednich
KR20180110181A (ko) 2010-09-10 2018-10-08 셈프라 파마슈티컬스, 인크. 질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드
IN2014DN08939A (tr) 2012-03-27 2015-05-22 Cempra Pharmaceuticals Inc
AU2014239959A1 (en) 2013-03-14 2015-10-01 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
EP2968384A4 (en) 2013-03-15 2017-02-15 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents
AU2014252462A1 (en) * 2013-04-10 2015-10-01 Probiotic Pharmaceuticals Aps Azithromycin antimicrobial derivatives with non-antibiotic pharmaceutical effect

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8506380D0 (en) * 1985-03-12 1985-04-11 Beecham Group Plc Chemical compounds
DE3668894D1 (en) * 1985-03-12 1990-03-15 Beecham Group Plc Erythromycin-derivate.
US5302705A (en) * 1989-10-07 1994-04-12 Taisho Pharmaceutical Co., Ltd. 6-O-methylerythromycin a oxime derivatives
US5719272A (en) * 1996-04-02 1998-02-17 Abbott Laboratories 2'-protected 3'-dimethylamine, 9-etheroxime erythromycin A derivatives
EP0895999A1 (en) * 1997-08-06 1999-02-10 Pfizer Products Inc. C-4" substituted macrolide antibiotics

Also Published As

Publication number Publication date
NO20014362D0 (no) 2001-09-07
HK1045697A1 (zh) 2002-12-06
BR0010518A (pt) 2002-01-08
SK13972001A3 (sk) 2002-08-06
ZA200107346B (en) 2002-11-27
AU3671000A (en) 2000-11-14
HUP0201116A3 (en) 2003-03-28
IL145256A0 (en) 2002-06-30
CZ20013497A3 (cs) 2002-05-15
HUP0201116A2 (en) 2002-08-28
NZ513998A (en) 2001-09-28
TR200102572T2 (tr) 2002-02-21
EP1167375A4 (en) 2002-10-30
PL354409A1 (en) 2004-01-12
CA2367319A1 (en) 2000-10-19
KR20020007333A (ko) 2002-01-26
AR023264A1 (es) 2002-09-04
CN1343216A (zh) 2002-04-03
WO2000061593A1 (fr) 2000-10-19
EP1167375A1 (en) 2002-01-02
BG105919A (en) 2002-06-28

Similar Documents

Publication Publication Date Title
IS5381A (is) 4-fenyl-pyridin afleiður
NO20021077D0 (no) Amino-triazolopyridin-derivater
ATE263748T1 (de) Admantan-derivate
NO20015172D0 (no) 1-Metyl-erytromycin-derivater
ATE293104T1 (de) Thiazolylamid-derivate
DK1147121T3 (da) Ketolidantibiotika
ATE377018T1 (de) Erythromycinderivate
DK1187814T3 (da) 5-phenyl-pyrimidinderivater
ATE338021T1 (de) Substituierte 2-dialkylaminoalkylbiphenyl- derivate
NO20021803L (no) Isoksazolkarboksamid-derivater
ATE257148T1 (de) Propargyletherderivate
NO20014362D0 (no) Erytromycinderivater
ATE374747T1 (de) Monofluoralkylderivate
DK1154988T3 (da) Mevinolinderivater
ATE293592T1 (de) Resorcinderivate
DK1218340T3 (da) 4-hydroxybiphenylhydrazid-derivater
DK1187815T3 (da) 4-phenyl-pyrimidinderivater
NO20020212L (no) 3-amino-2-benzyl-1-fenyl-propanderivater
NO20022867D0 (no) Syklopentenon-derivater
PT1088818E (pt) Derivados de quinolin-4-ilo
PT1194401E (pt) Derivados de diacil-hidrazina
DK1189886T3 (da) Ethansulfonyl-piperidinderivater
DE60001736D1 (de) 1-trifluorotmethyl-4-hydroxy-7-piperidinyl-aminomethylchroman-derivate
NO20015380D0 (no) Tio-oksindolderivater
DE59909774D1 (de) 1-cycloalkylpyrazolyl-benzoyl-derivate

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application